Carmen Kerschbaum

Senior Executive, CFO & COO, Life Sciences Executive & Investor

Carmen is a recognized leader and advisor in finance, operations, digital, business development and strategic innovation across global life sciences and automotive industry. With over 20 years of finance and operational expertise, including more than 15 years in the healthcare sector, she brings a unique perspective on the needs of patients, the role of investors, and the rapidly evolving healthcare landscape. Most recently, Carmen was the SVP Finance for Pfizer Worldwide Research and Development, Oncology Division (CFO) and Business Innovation (incl. M&A and Portfolio/Strategy Finance. In this role, she prioritized internal and external investments for Pfizer's R&D pipeline, led business development activities, fostered ecosystem relationships, and oversaw the creation of a new Oncology division including the integration of Seagen. Prior to Pfizer, Carmen held global finance, strategy, partnerships, and operational leadership roles at Roche / Genentech. Before joining Roche/Genentech, she served as Corporate Controller for Behr America, where she was responsible for all aspects of financial planning, business finance, analytics and management. With fluency in multiple languages, she has a global mindset, strong understanding of international operations and a proven track record of effectively building and leading diverse cross-functional teams. Carmen earned a M.B.A. and Process Engineering degree from the University of Stuttgart, Germany.